BackLakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Overview
LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) P/E Ratio

Valuation check: LSBPW's P/E ratio is -0.48, below the sector sector average of 24.91.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

-0.48

P/E Ratio

-0.48

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) (LSBPW) FAQ

The latest P/E ratio for LSBPW is -0.48. That is below the sector sector average of 24.91. Investors often review this figure alongside LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s historical trend and sector peers before judging valuation or financial health.

Against its sector companies, LSBPW currently prints -0.48 for P/E ratio, while the sector average sits near 24.91. That is roughly 101.9% below the sector mean. Large gaps often invite a closer look at LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s growth, margins, and balance sheet.

A P/E ratio of -0.48 for LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) is not 'good' or 'bad' on its own. Compare it with the peer average (24.91) and with LSBPW's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting LSBPW's P/E ratio (-0.48), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.